Author of The cancer-immunity cycle (Immunity 2013) and the cancer-immune set point (Nature 2017) with Ira Mellman.
A pioneer in the field of Cancer Immunotherapy, emergence of PD-L1/PD-1 inhibitors and next generation therapies. Experienced drug developer (from pre-clinical through Phase I-IV), strong communicator and strategic leader with expertise in Oncology, Immunology, Filings, Biomarkers and Building/Leading Organizations.